biopharmaceutical industry

Samsung Biologics Partners with Kurma for Biologics Development and Manufacturing

Samsung Biologics, a global contract development and manufacturing organization (CDMO), and Kurma Partners, a European venture capital firm in healthcare and biotechnology, recently announced a strategic partnership for the development and manufacturing of biologics for Kurma Partners’ portfolio companies.

Never Compromise

Lilly Wins Court Ruling on Alimta Patent

Sartorius Stedim Biotech Buys BioOutsource

Ending Drug Trial Secrecy Is a Boon for R&D, Says EU Agency